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The microbiome is being characterized by large-
scale sequencing efforts, yet it is not known whether
it regulates host metabolism in a general versus
tissue-specific manner or which bacterial metabo-
lites are important. Here, we demonstrate that micro-
biota have a strong effect on energy homeostasis in
the colon compared to other tissues. This tissue
specificity is due to colonocytes utilizing bacterially
produced butyrate as their primary energy source.
Colonocytes from germfree mice are in an energy-
deprived state and exhibit decreased expression of
enzymes that catalyze key steps in intermediary
metabolism including the TCA cycle. Consequently,
there is a marked decrease in NADH/NAD+, oxidative
phosphorylation, and ATP levels, which results in
AMPK activation, p27kip1 phosphorylation, and au-
tophagy. When butyrate is added to germfree colo-
nocytes, it rescues their deficit in mitochondrial
respiration and prevents them from undergoing au-
tophagy. The mechanism is due to butyrate acting
as an energy source rather than as anHDAC inhibitor.
INTRODUCTION
Diverse microbial communities reside at various sites within the
human body (Camp et al., 2009; Eckburg et al., 2005; Savage,
1977). These microbiota and their genomes, referred to collec-
tively as the microbiome, are being characterized by metage-
nomic sequencing as part of the Human Microbiome Project
(Gill et al., 2006; Hildebrandt et al., 2009; Kurokawa et al.,
2007; Qin et al., 2010; Turnbaugh et al., 2007, 2009). The vast
majority of microbes are bacteria that reside in the gut and are
estimated to number 100 trillion, which is 10-fold greater than
all of somatic and germ cells in the human body (Savage,
1977; Turnbaugh and Gordon, 2009). Moreover, taking the
genetic diversity of the microbiome into account, it is estimated
to harbor at least 100-fold more genes than the human genome
(Hooper and Gordon, 2001). Based on current 16S and metage-
nomic sequence data, the gut microbiome is highly enriched for
genes involved in energy production and metabolism (Gill et al.,C2006; Qin et al., 2010; Turnbaugh et al., 2009). These findings
suggest that microbiota help facilitate the host’s ability to extract
calories from their diet, but sequence-based data must be vali-
dated by experiments that investigate function.
To investigate the effect of the microbiome in host metabo-
lism, germfree (GF) animals lacking microbiota have been
studied (Gordon and Pesti, 1971; Hooper and Gordon, 2001;
Wostmann, 1981). For example, GF mice have been compared
to genetically identical mice that were raised conventionally
(CONV-R) with ‘‘normal,’’ albeit undefined, microbiota. These
studies support the idea that microbes increase host metabolic
efficiency (Ba¨ckhed et al., 2004; Turnbaugh et al., 2006, 2008,
2009; Turnbaugh and Gordon, 2009). For example, GF mice
must consume 10%–30% more food to maintain the same
body weight as CONV-R controls (Ba¨ckhed et al., 2004; Gordon
and Pesti, 1971). Despite this increased food intake, GFmice are
leaner with an 40% decrease in the size of their epididymal fat
pads (Ba¨ckhed et al., 2004). They have a similar decrease in liver
glycogen levels. GF mice also have lower blood glucose and
insulin levels and are resistant to obesity induced by a high-fat
diet (Ba¨ckhed et al., 2007). However, these findings are compli-
cated by the observation that GF mice exhibit increased loco-
motor activity (Ba¨ckhed et al., 2007). Therefore, the increased
food consumption and decreased body fat of GF mice may
simply be due to increased energy expenditure. To demonstrate
that microbiota directly affect metabolism, individual tissues
from GF and CONV-R mice must be assessed for differences
in key metabolic parameters (Camp et al., 2009). This approach
has the potential to reveal general mechanisms as to howmicro-
biota regulate metabolism as well as to identify tissue-specific
differences.RESULTS
Microbiota Influence Energy Homeostasis in the Colon
To investigate whether microbiota have tissue-specific effects
on host metabolism, we analyzed two key biomarkers of energy
homeostasis, NADH/NAD+ ratios and ATP levels, in several
tissues from GF and CONV-R mice. We found no significant
differences for either biomarker in liver, heart, kidney, or testis
(Figures 1A and 1B). These results are consistent with previous
studies from liver and heart of nonfasted GF and CONV-R
mice (Ba¨ckhed et al., 2007; Crawford et al., 2009). In stark
contrast, NADH/NAD+ and ATP levels are significantlyell Metabolism 13, 517–526, May 4, 2011 ª2011 Elsevier Inc. 517
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A B Figure 1. Effects of Microbiota on Energy
Homeostasis
Total NADH/NAD+ ratios (A) and ATP levels (B) in
various tissues fromGF andCONV-Rmice. L, liver;
H, heart; K, kidney; T, testis; C, colon. Six GF and
six CONV-R mice were analyzed, and results are
mean ± standard error (SE). Significant differences
are indicated (**p < 0.01).
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Role of Microbiome and Butyrate in Metabolismdiminished in GF colon by 16-fold and 56%, respectively. These
results indicate that microbiota have a particularly important role
in regulating host metabolism in the colon.
Microbiota Regulate the Abundance of mRNAs
and Proteins Involved in Metabolism
To understand the effects of microbiota on colonocyte metabo-
lism, we performed transcriptome profiling and quantitative
mass spectrometry on freshly isolated colonocytes from GF
and CONV-R mice. For the transcriptome profiling experiments,
we identified 624 genes that are upregulated and 813 genes are
downregulated in GF compared to CONV-R. All of these gene
expression changes are statistically significant with false
discovery rates below 0.01. The entire data set and statistical
values are included as Table S1 (available online). Our transcrip-
tome data includes genes previously shown to be regulated by
microbiota in various tissues of zebrafish, mice, and piglets.
For example, Angpt14/Fiaf is upregulated in GF compared to
CONVwhileGpx2, ApoB, Aqp4, and Pla2g4c are downregulated
(Ba¨ckhed et al., 2004; Chowdhury et al., 2007; Cresci et al., 2010;
Esworthy et al., 2003; Rawls et al., 2004). Several genes from ourA B 
Figure 2. Analysis of Microbiome Regulated Gene Products and Metabolites
Top KEGG pathways of transcriptome (A) and proteome (B) identified as differences between GF and CONV-R
the y axis at left. Straight yellow lines represent threshold of significance for these –log (p values). Yellow box
and indicate the number of genes or proteins affected divided by total number within category. Six GF and
analysis. For the proteome analysis, three GF and three CONV-R mice were used. See also Figures S1–S3.
518 Cell Metabolism 13, 517–526, May 4, 2011 ª2011 Elsevier Inc.list were validated by RT-qPCR. In each
case, the RT-qPCR data confirm the tran-
scriptome profiling result (Figure S1A).We also used quantitative mass spectrometry to assess
proteomic differences between GF and CONV-R colonocytes.
Using a two-dimensional shotgun mass spectrometry approach,
we identified 2120 proteins per sample with no significant
difference in the number of proteins identified between GF and
CONV-R samples. Poisson regression analysis and normaliza-
tion of individual spectral counts revealed that 136 proteins
were upregulated and 80 proteins were downregulated in GF
compared to CONV-R (p values < 0.05). The entire protein list
and statistical values are included as Table S2. A number of
the differentially expressed proteins were confirmed by western
blot analysis (Figure S1B).
To identify biological pathways that are regulated by micro-
biota, we used ingenuity pathway analysis (IPA) to analyze
differences in gene expression. For both the transcriptome and
proteome data, all of the top Kyoto Encyclopedia of Genes and
Genomes (KEGG) categories havemetabolic functions (Figure 2).
There was significant concordance with themajority of the KEGG
categories at the proteome level (Figure 2B) also being repre-
sentedat the transcriptome level (Figure2A). Thisoverlap includes
pathways that metabolize butyrate, which is a short-chain fatty. Blue bars correspond to –log (p values) shown on
es represent the ratio, shown on the y axis at right,
six CONV-R mice were used for the transcriptome
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Role of Microbiome and Butyrate in Metabolismacid (SCFAs) produced by microbes in the lumen of the colon at
high (mM) levels. Butyrate is noteworthy because it is a histone
deacetylase (HDAC) inhibitor that regulates gene expression
and also serves as the primary energy source for the colonic
epithelium (Boffa et al., 1978; Candido et al., 1978; Dashwood
et al., 2006; Garcea and Alberts, 1980; Roediger, 1980, 1982).
Considering that butyrate is a fatty acid oxidized in the mitochon-
dria, it is reasonable that genes involved in fatty acid metabolism,
glycerolipidmetabolism, the tricarboxylic acid (TCA) cycle, oxida-
tive phosphorylation, and mitochondrial dysfunction are also
among the top KEGG categories (Figure 2).
To provide additional insight into the role of microbiota in
metabolism, we performed 1H NMR-based metabolomics on
GF and CONV-R colonocytes. A principal components analysis
scores plot revealed significant differences between GF and
CONV-R samples (Figure S2). A number of metabolites differ
between GF and CONV-R including glucose, lactate, creatine,
glutamate, various amino acids, and 3-hydroxybutyrate (Fig-
ure S3). A number of amino acids, including alanine, glutamine,
and branched chain amino acids such as isoleucine and valine,
are elevated in GF colonocytes. These changes support the
transcriptome and proteome data sets showing multiple KEGG
categories related to amino acid metabolism. Additionally,
3-hydroxybutyrate (3-HB), a metabolic product of fatty acid and
butyrate metabolism (two of the top KEGG categories), was
significantly decreased inGFcompared toCONV-Rcolonocytes.
Microbial Regulation of Oxidative Metabolism
Based on our transcriptome and proteome data, microbiota
regulate enzymes that catalyze reactions in intermediary metab-
olism. For example, three out of six enzymes involved in b-oxida-
tion of fatty acids are downregulated including the acyl CoA
dehydrogenase specific for SCFAs such as butyrate. To confirm
that fatty-acid oxidation is diminished, we incubated freshly
isolated colonocytes from CONV-R and GF mice with 13C-buty-
rate and measured conversion to labeled CO2. These experi-
ments indicate GF colonocytes have a 31% decrease in labeled
CO2 compared to CONV-R (Figure 3A).
In addition to fatty-acid oxidation, the pyruvate dehydroge-
nase (PDH) complex is the other major pathway that gives rise
to acetyl-CoA, and it is also downregulated in GF colonocytes.
Therefore, we measured acetyl-CoA levels, and we observed
a 30% decrease in GF compared to CONV-R (Figure 3B).
Acetyl-CoA enters the TCA cycle, and five out of eight TCA cycle
enzymes are downregulated at the mRNA and/or protein level.
To test whether diminished substrate and enzymes levels result
in decreased TCA cycle function, we measured two TCA cycle
intermediates. As expected, both malate and oxaloacetate are
significantly diminished in GF (Figures 3C and 3D).
A primary objective of the TCA cycle is to reduce NAD+ to
NADH, which enters the electron transport chain, where oxida-
tive phosphorylation culminates in ATP production. Diminished
TCAcycle activity inGFcolonocytes should result in a diminished
NADH/NAD+ ratio in the mitochondria. To test this hypothesis,
we isolated mitochondria from GF and CONV-R colonocytes
and measured NADH and NAD+ by HPLC/LC-MS (Figure S4).
Quantification of these data demonstrated that themitochondrial
NADH/NAD+ ratio was 0.061 ± 0.022 in GF compared to 13.56 ±
1.2 for CONV-R (Figures 3E and 3F).CTo test whether the altered redox state results in diminished
oxidative phosphorylation, we isolated colonocytes from GF
and CONV-R mice and incubated them ex vivo with two mito-
tracker probes simultaneously. One probe fluoresced red upon
being oxidized and provided a measure of oxidative phosphory-
lation (i.e., mitochondrial respiration), while the other probe
fluoresced green regardless of mitochondrial respiration and
therefore served as an internal control. As shown in Figure 3G,
GF colonocytes exhibit a marked decrease in mitochondrial
respiration (red in top row) but no difference in total mitochondria
(green in middle row). The extent to which oxidative respiration is
decreased in GF colonocytes is surprising because it more
closely resembles sodium azide (NaN3)-treated negative
controls than the CONV-R samples. Quantification of differences
between these groups revealed a 70% drop in the rate of oxida-
tive phosphorylation in GF compared to CONV-R (Figure 3H).
These results are consistent with a significantly diminished mito-
chondrial NADH/NAD+ ratio (Figures 3E and 3F) and the reduc-
tion in ATP levels (Figure 1B) previously identified. Decreased
ATP levels in GF colonocytes are also compatible with
decreased protein expression of both a and b catalytic subunits
of F1-ATP synthase (Figure 3I and Figure S1B).
Energy Deprivation in GF Colonocytes Leads
to Autophagy
Considering that GF colonocytes have ATP levels that are less
than half of CONV-R controls, one might expect them to exhibit
signs of energetic stress. AMPK (50-adenosine monophosphate-
activated protein kinase) is a metabolic sensor activated by
falling ATP and/or rising AMP levels (Shaw et al., 2004). As ex-
pected, GF colonocytes have increased AMPK activation based
on increased Thr172 phosphorylation (Figure 4A). In addition, we
discovered that total AMPK levels are elevated in GF colono-
cytes (Figure 4A and Figure S5).
In response to nutrient deprivation, AMPK activation induces
autophagy, which is a catabolic process where the cell degrades
its own cellular components in an attempt to maintain energy
homeostasis (He and Klionsky, 2009; Yang and Klionsky, 2009).
AMPK can induce autophagy by phosphorylating (Thr198) and
stabilizing the cyclin-dependent kinase inhibitor 1B (p27kip1)
(Liang et al., 2007). Therefore, we analyzed GF colonocytes and
observed increased Thr198 phosphorylation compared to
CONV-R controls (Figure 4B). Since AMPK and p27kip1 activation
are higher in GF colonocytes, we expected that autophagywould
also be increased. In support of this hypothesis, we detected
increased levels of the autophagosome marker LC3-II in GF
compared to CONV-R colonocytes (Figure 4C). In addition, we
performed transmission electron microscopy (TEM) on colonic
tissue to detect double-membrane autophagosomes. TEM
ultramicrographs showed one or two autophagosomes per GF
colonoycte compared to only one autophagosome for every
30 cells in CONV-R colons (Figure 4D). These findings indicate
that microbiota decrease autophagy in the colon.
Butyrate-Producing Microbes Rescue GF Energetics
and Autophagy
To demonstrate that the energy-deprived state and increased
autophagy observed in GF colonocytes are a direct result of
absence of microbes, we colonized GF mice with microbiotaell Metabolism 13, 517–526, May 4, 2011 ª2011 Elsevier Inc. 519
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Figure 3. Regulation of Colonocyte Oxidative Metabolism
(A) Percentage of 13C-butyrate metabolized to 13CO2 in CONV-R and GF colonocytes.
(B–D) Measurement of intermediary metabolites. Levels of acetyl-CoA (B), malate (C), and oxaloacetate (D) in CONV-R and GF.
(E and F) Levels of mitochondrial NADH and NAD+ in CONV-R (E) and GF (F) colonocytes. The different scales reflect different amounts of material loaded and
detected by HPLC-LC-MS.
(G) Oxidative metabolism indicated byMitoTracker Red CM-H2XRos (red fluorescence; top panel) andMitoTracker Green FM (green fluorescence; middle panel)
in colonocytes from CONV-R, CONV-R with NaN3 (sodium azide, negative control), or GF.
(H) Quantification of oxidative metabolism in different experimental groups.
(I) Spectral counts from quantitative mass spectrometry of ATP synthase F1a and b.
Results in (A)–(D), (G), and (H) are displayed as mean ± SE and significant differences are identified (*p < 0.05, **p < 0.01). For (A)–(D), four GF and four CONV-R
mice were used. In (E)–(H), three mice were used per condition. See also Figure S4.
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Role of Microbiome and Butyrate in Metabolismderived from CONV-R mice thus converting GF mice into
CONV-D (conventionally derived) mice. In addition to colonizing
GF mice with a complete microbiota, we also colonized GF mice
with a butyrate-producing bacterial strain called Butyrivibrio
fibrisolvens (Diez-Gonzalez et al., 1999; Rumney et al., 1995).
We then tested whether a complete colonization or colonization
withB. fibrisolvens for three weeks would rescue oxidative phos-
phorylation, ATP levels, and autophagy. Mitotracker experi-
ments clearly showed that CONV-D and B. fibrisolvens colono-
cytes exhibit the same degree of oxidative phosphorylation as
CONV-R (Figures 5A and 5B). We also found similar ATP levels
in CONV-D, B. fibrisolvens, and CONV-R colonocytes (Fig-
ure S6A). Finally, consistent with the ability of complete micro-520 Cell Metabolism 13, 517–526, May 4, 2011 ª2011 Elsevier Inc.biota and B. fibrisolvens to restore energy homeostasis, these
bacteria also restore autophagy to normal levels based on the
LC3-II marker (Figure S6B).Butyrate Functions as an Energy Source Rather
than an HDAC Inhibitor
To provide direct evidence that butyrate is a causal factor, we
added butyrate to GF colonocytes while they were being isolated
over a 30–60 min period. Butyrate had a dramatic effect ex vivo,
increasing oxidative phosphorylation in GF from 30% to 70% of
CONV-R levels (Figures 5A and 5B). We also tested whether
butyrate inhibits autophagy in GF colonocytes. As expected, it
Figure 4. Microbial Regulation of Energy Metabolism and Autophagy
(A–C) Western blot analysis of phosho-AMPKa and AMPKa (A), phospho-p27 (B), and LC3-I and -II (C) with histone H3 or b-actin as loading controls in CONV-R
and GF.
(D) Transmission electron micrographs of CONV-R and GF colonic epithelium. Lysosomes (L) and autophagosomes (a) are indicated, and arrows show double
membrane of autophagasome in inset.
For (A)–(C), western blots are representative of four experiments with two CONV-R and two GF mice with two technical replicates each.
See also Figure S5.
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Role of Microbiome and Butyrate in Metabolismdecreases p27 phosphorylation and LC3-II compared to un-
treated GF colonocytes (Figures 5C and 5D).
Since butyrate is a SCFA and an HDAC inhibitor, it could
rescue the GF defects by acting either as an energy source or
epigenetic factor (Boffa et al., 1978; Candido et al., 1978; Dash-
wood et al., 2006; Garcea and Alberts, 1980; Roediger, 1980,
1982). To distinguish between these two possible mechanisms,
we repeated the butyrate rescue experiments but added
a compound that blocks fatty-acid oxidation. This pharmacolog-
ical inhibitor, etomoxir, prevents butyrate from increasing oxida-
tive phosphorylation in mitotracker experiments (Figures 5A and
5B). It also prevents butyrate from suppressing autophagy in GF
colonocytes (Figure 5E).
The data presented above demonstrate that butyrate main-
tains energy homeostasis and prevents autophagy by acting
as an energy source rather than as an HDAC inhibitor. To provide
additional support for this mechanism, we performed mito-
tracker experiments with three molecules with defined actions
similar to butyrate. Propionate is a SCFA that enters the TCA
cycle through succinyl-CoA to function as an energy source
and an HDAC inhibitor (Hinnebusch et al., 2002; Waldecker
et al., 2008). In contrast, palmitate is a long-chain fatty acid
(LCFA) that enters the TCA cycle as acetyl-CoA and only func-
tions as an energy source, whereas trichostatin A (TSA) only
functions as an HDAC inhibitor. Consistent with the data pre-
sented above, propionate and palmitate stimulate mitochondrial
respiration while TSA has no effect (Figure S7).CDISCUSSION
Many fundamental questions about how the microbiome regu-
lates host metabolism have yet to be addressed. For example,
does it have general or tissue-specific effects? Also, which
bacterial metabolites have important biological activities? In
our study, we demonstrate that microbiota have a strong effect
maintaining NADH/NAD+ ratios and ATP levels in the colon but
not liver, heart, kidney, or testis. We attribute this tissue speci-
ficity to the fact that colonocytes utilize bacterially produced
butyrate as their primary energy source, whereas most other
cell types utilize glucose. The lumen of the colon has the highest
density of microbes in the body, and specific bacteria belonging
to genera such as Clostridium, Eubacterium, and Butyrivibrio
ferment dietary fiber into butyrate at very high (mM) concentra-
tions (Barcenilla et al., 2000; Pryde et al., 2002). As shown in Fig-
ure 6, butyrate is a SCFA transported into colonocytes, enters
the mitochondria, and undergoes b oxidation to acetyl-CoA,
which enters the TCA cycle resulting in the reduction of NAD+
to NADH. NADH enters the electron transport chain culminating
in ATP production with CO2 as a byproduct.
Our transcriptome and proteome experiments identified buty-
rate metabolism as the most affected pathway in GF colono-
cytes followed by related oxidative metabolic pathways. In GF
colonocytes, the absence of microbial butyrate results in each
one of the above metabolic processes (e.g., b oxidation, TCA
cycle, oxidative phosphorylation) being diminished, which isell Metabolism 13, 517–526, May 4, 2011 ª2011 Elsevier Inc. 521
Figure 5. Colonization and Butyrate Rescue Diminished Oxidative Metabolism
(A) Mitochondrial respiration indicated by MitoTracker Red CM-H2XRos (red fluorescence; top panel) and MitoTracker Green FM (green fluorescence; middle
panel) in colonocytes from CONV-R, CONV-D, B. fibrisolvens, GF, GF with 10 mM butyrate, and GF with both 10 mM butyrate and 500 mM etomoxir.
(B) Quantification of mitochondrial respiration in different experimental groups.
(C–D) Western blot analysis of phospho-p27 (C) and LC3-I and -II (D) with and without 10 mM butyrate in CONV-R and GF with b-actin as loading controls.
(E) Western blot analysis of LC3-I and –II of GF, GF with 10 mM butyrate, and GF with 10 mM butyrate and 500 mM etomoxir.
For (A) and (B), a total of threemice per condition were used, and results are displayed asmean ± SE, with significant differences indicated (**p < 0.01). For (C)–(E),
western blots are representative of four experiments with two CONV-R and two GF mice with two technical replicates each. See also Figures S6 and S7.
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Role of Microbiome and Butyrate in Metabolismcorrelated with key enzymes being downregulated (Figure 6). To
demonstrate the importance of butyrate relative to other micro-
bial metabolites, we rescued each of these processes by colo-
nizing GF mice with butyrate-producing bacteria as well as by
adding exogenous butyrate to GF colonocytes.
Considering that GFmice have colonocytes with less than half
of normal ATP levels, one might expect them to exhibit signs of
impaired colonic function. In fact, GF mice drink more water
than CONV-R controls and exhibit mild diarrhea, both of which
are indicative of perturbed water reabsorption (Gordon and
Pesti, 1971). However, colonocyte function must be partially
retained because GF mice do not die prematurely due to diar-
rhea-induced dehydration. Our results suggest this is due to
GF colonocytes adapting to their suboptimal energetic state by
undergoing autophagy. Reduced ATP levels activate AMPK,
which, in turn, activates p27 to prevent apoptosis and induce
autophagy in these cells (Figure 6). Autophagy involves protein
catabolism and attenuated translation, giving rise to amino acids
that can then be used for energetic purposes. Our NMR experi-
ments found increased levels of amino acids, including branched
chain amino acids, in GF compared to CONV-R colonocytes.
The branched chain amino acids are the major nitrogen source
for glutamine and alanine, which are also clearly elevated in
the GF colonocytes. With this in mind, it is clear that microbes
regulate energy homeostasis in the colon, and in the absence522 Cell Metabolism 13, 517–526, May 4, 2011 ª2011 Elsevier Inc.of microbiota, autophagy is used as a mechanism to derive
amino acids that can be diverted toward energy production.
Dietary factors known as prebiotics promote the growth of
certain bacteria at the expense of others and have implications
for human health and disease. As our diets have shifted away
from fiber and other complex carbohydrates toward processed,
simple carbohydrates, the incidence of colorectal cancer (CRC)
and inflammatory bowel diseases (IBDs) such as ulcerative colitis
and Crohn’s disease have increased (Garcea and Alberts, 1980;
Hamer et al., 2008; Latella and Caprilli, 1991). It is possible that
increasing butyrate levels in the lumen and in colonocytes could
help reverse this trend. In fact, butyrate enema therapy has been
shown to ameliorate the inflammation associated with colitis in
mouse models and in human clinical trials (Hamer et al., 2008).EXPERIMENTAL PROCEDURES
Animals
Eight- to 14-week-old male C57BL/6 mice were used in all experiments.
Conventionally raised mice were reared in a specific pathogen-free (SPF)
facility, while germfree mice were maintained according to standard operating
procedures at the National Gnotobiotic Resource Center at UNC. Detailed
information is available from their website (http://www.med.unc.edu/ngrrc/
about-us/) and upon request. All experiments were performed using protocols
approved by the Institutional Animal Care and Use Committees (IACUC) of
UNC and in accordance with federal guidelines.
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Figure 6. Microbial Regulation of Colono-
cyte Metabolism
Schematic showing that dietary fiber is fermented
bymicrobes into butyrate in the lumen of the colon,
which is transported into the colonocyte. In the co-
lonocyte, butyrate promotes oxidative metabolism
and inhibits autophagy. Based on transcriptome
and proteome experiments, enzymes regulated by
microbes are boxed. In all cases, boxed enzymes
that function in b-oxidation and the TCA cycle are
downregulated in GF colonocytes, revealing that
microbes positively regulate their expression.
DiminishedATP results in phosphorylation of AMPK
and p27, which culminates in autophagy.
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Colonic epithelial cells were isolated as previously described (Roediger and
Truelove, 1979) in order to exclude cell types other than colonocytes such
as immune cells, smooth muscle, and enteric neurons. In brief, animals were
euthanized by CO2 asphyxiation followed by cervical dislocation. Proximal
colons were dissected, flushed with sterile phosphate-buffered saline (PBS)
and splayed open longitudinally along Whatmann paper. The colon was then
washed three more times in PBS, pealed from paper, and placed in PBS solu-
tion containing 5mMEDTA. Submerged colon was then incubated on a rotator
for30min at 37C. Colonic tissue was removed leaving isolated colonocytes,
which were pelleted, washed twice with PBS, and used for experiments.
Transcriptome Analysis
Colonocytes were prepared from GF and CONV-R mice (three biological repli-
cates each) and flash-frozen. Total RNA was prepared with Trizol reagent
(Invitrogen, Carlsbad, CA), and integrity was assessed with the RNA 6000
Nano-LabChip kit followed by analysis with a Bioanalyzer (Agilent, Palo Alto,
CA). Hybridizations to the MouseWG-6 v2.0 BeadChip arrays (Illumina, San
Diego, CA), washing, and scanning was performed at the University of Tennes-
see at Memphis Core Facility. Data were analyzed with R/limma (Smyth, 2004).
Quantitative Mass Spectrometry
Whole-cell proteins from colonocyteswere extracted by sonication in a buffer of
8 M urea, 25 mM Tris (pH 7.6), and 100 mM NaCl for 5 min. Proteins were sub-Cell Metabolism 13, 517jected to overnight trypsin digestion followed by
isoelectric focusing of peptides on a pH3.5–4.5
immobilized pH gradient strip. Peptides were then
further separated by reverse-phase LC coupled in-
line with a linear ion-trap mass spectrometer. MS
and MS/MS sans were acquired with data-depen-
dent settings and searched against a NCBI mouse
proteome database (ftp://ftp.ncbi.nih.gov/refseq/
M_musculus/mRNA_Prot/mouse.protein.faa.gz).
Resultswere filteredusingan inhousederivedalgo-
rithm.Quantificationwasperformedwith redundant
spectral counting where spectral counts (SCs) for
an individual protein are normalized to the overall
spectra collected in each fraction for the individual
and then by total spectral counts for all proteins
(Carvalho et al., 2008a, 2008b; Kislinger et al.,
2006).More details of digestionconditions, acquisi-
tion and search parameters, and data filtering algo-
rithms and quantification statistics are described in
the Supplemental Experimental Procedures.
NMR Metabolomics
Colonocytes were processed with the methanol-
chloroform-water method (Beckonert et al.,
2007), and the polar phase was lyophilized, stored
at 80C, thawed and suspended in 550 ml of
a 1.0 mM solution of 2,2-dimethyl-silapentane-5-sulfonate sodium salt (DSS)
containing 0.01% (w/v) sodium azide as a bacteriocide. The solutions were
transferred to 5mmNMR tubes. NMR spectra were acquired on a Varian Inova
600 MHz with a 5 mm pulsed field gradient, inverse detection probe (Varian,
Palo Alto, CA). The spectra were acquired at 25C with 2048 transients with
a sweep width of 6900 Hz and digitized with 32K points. The pulse sequence
included a 1 s solvent presaturation period and a 3.4 s acquisition time. The
data were processed with the ACD NMR Manager software version 12
(Advanced Chemistry Development, Toronto, Canada). A 0.3 Hz exponential
line broadening was applied to the data. The spectra were phased, baseline
corrected, and integrated with high-resolution binning with bin widths of
0.001 ppm. The regions from 0.5 to 4.7 ppm and 4.9 to 9.0 were included in
the integration. The regions below 0.5 and above 9.0 contained only noise
and the region from 4.7 to 4.9 contained the residual solvent peak. The data
were normalized by setting the sum of all integrals equal to 1000 for each spec-
trum.Metabolite identificationwas facilitated by theChenomxNMRmetabolite
database, version 6 (Chenomx, Edmonton, Canada). The statistical analyses
including principal components analysis (PCA) and partial least-squares
(PLSs) were performed with SimcaP+ version 12 (Umetrics, Umea, Sweden).
Pareto scaling was applied to the binned NMR data prior to statistical analysis.
Butyrate Oxidation to CO2
Colonocytes were incubated in Exetainer breath storage tubes with a 4% 13C-
butyrate and 96%unlabeled butyrate for 1 hr at 37C and stoppedwith sodium–526, May 4, 2011 ª2011 Elsevier Inc. 523
Cell Metabolism
Role of Microbiome and Butyrate in Metabolismazide treatment. The amount of 13CO2 generated from the colonocytes was
measured with a 20/20 gas isotope ratio mass spectrometer (Europa Scien-
tific, Cincinnati, OH) at Metabolic Solutions (Nashua, NH). Dissolved CO2 in
solution was liberated to the tube headspace by addition of 100 ul saturated
citric acid. The ratio of 13CO2 to
12CO2 (mass 45 to 44) was measured directly
from the sample tube headspace. All samples were compared to an internal
reference gas (5% CO2, balance 75% N2, 20% O2) that had been calibrated
against the International standard PeeDeeBelmnite (PDB). The results were
expressed as the delta (d) value per mil (%) and then converted to units of
atom % 13C and defined by: atom % 13C = 13CO2 / (
13CO2 +
12CO2) 3
100%. Changes in 13CO2 enrichment before and after butyrate administration
were calculated. CO2 standards at three different
13C enrichments were run
before and after the run to check instrument performance. The analytical preci-
sion of the instrument is 0.0001 atom % 13C.
HPLC/LC-MS Analysis of NADH/NAD+
Mitochondria were isolated from CONV-R and GF colon in accordance to the
manufacture’s instructions with the mitochondrial isolation kit from Biovision
(Mountain View, CA). Isolated mitochondria were then resuspended in 0.1%
ammonium hydroxide and were analyzed for NAD+ and NADH content by
HPLC separation with subsequent detection by a triple-quadrupole mass
spectrometer operating in positive mode. Peak areas were calculated with
ThermoXcaliber (San Jose, CA). Chromatographic peaks were integrated for
samples and areas were compared to peak area for standards (5 pmol) for
each compound. Further details concerning the methodology are included in
the Supplemental Experimental Procedures.
Metabolic Assays
All metabolic assays were performed with Biovision (Mountain View, CA)
metabolism kits. Specifically, acetyl-CoA (K317-100), malate (K637-100),
oxaloacetate (K659-100), NAD/NADH (K337-100), and ATP (K354-100) were
used in accordance to manufacturer specifications. For all assays, flash-
frozen tissue was deproteinized with Perchloric acid kit (K808-200), which
was also purchased from Biovision. All experiments were performed on four
to six independent biological replicates and two technical replicates per exper-
imental group.
Confocal Microscopy
The reagents MitoTracker Red CM-H2XRos, and MitoTracker Green FM were
purchased from Invitrogen (Carlsbad, CA). Cells were viewed with Olympus
IX81 confocal microscope equipped with FITC, Texas Red, Rhodamine, and
DAPI filters. All fluorescent micrographs were acquired with the same expo-
sure and focal plane. Image J (Bethesda, MD) was used to quantify integrated
density (total fluorescence) per cell. Mitotracker dyes were added at 500 nM
(MitoTracker Red CM-H2XRos), and 500 nM (MitoTracker Green FM) while
isolating colonocytes. Image J was used to analyze mean fluorescence for
both mitotracker dyes. The red-to-green fluorescence is an indication of
oxidative metabolism in the colonocytes. All micrographs were taken with
identical exposures. Z stacks were acquired for each image and for each
cell the individual Z stacks did not differ in red-to-green mean fluorescence
between focal planes. Three independent biological replicates were analyzed
per experimental group.
Western Blot Analyses
Colonocytes or tissues were prepared as described above, except in butyrate
rescue experiments, where 10 mM butyrate was added during the isolation of
colonocytes. Cells or tissues were flash frozen, and homogenized or agitated
in 8.3 M urea lysis buffer (Reyes et al., 1997) with NaF and Na orthovanadate
and incubated on wet ice for 30 min. Samples were then centrifuged at
14,000 rpm for 20 min at 4C. Protein supernatant was transferred to a new
1.5 ml eppendorf tube and protein concentration was determined by Bradford
assay. Protein homogenates were separated on 10%, 12%, and 4%–20%
gradient SDS-polyacrylamide gels and transferred onto PVDF membrane.
Membranes were then incubated on rocker in 3% BSA or 5% nonfat dry
milk with NaF for 1 hr at room temperature (RT). Blocked membranes were
incubated in 1C Ab overnight on rotator at 4C. Antibodies were used at
1:250 to 1:2000 and included pyruvate dehydrogenase cocktail (Mitosciences,
Eugene, OR; MSP02), ATP synthase F1b (Invitrogen, Carlsbad, CA; A-21351),524 Cell Metabolism 13, 517–526, May 4, 2011 ª2011 Elsevier Inc.phospho-AMPK (Cell Signaling), AMPKa (Cell Signaling, Danvers, MA), LC3
(Cell Signaling, Danvers, MA), phospho-p27 (R&D Systems; YXH02), b-actin
(Abcam; ab8226), and total Histone H3 (Upstate; 05-928). Blots were washed
33 for 10 min/wash in 13 TBST or 13 PBST (for nonphospho westerns) at RT
and incubated with horseradish peroxidase-conjugated secondary antibodies
(1:2000 to 1:4000) for 1 hr and 30 min on rocker at room temperature.
Membranes were then washed three additional times in 13 TBST or 13
PBST (for nonphospho westerns), treated with ECL reagent, and developed
for analysis.
Transmission Electron Microscopy
Tissues were dissected, rinsed with PBS, and fixed in 0.15 M sodium phos-
phate buffer (pH 7.4) containing 2% paraformaldehyde and 2.5% glutaralde-
hyde overnight. After buffer washes, the tissue was postfixed for 1 hr with
1% osmium tetroxide/0.15M sodium phosphate buffer. Samples were dehy-
drated with increasing concentrations of ethanol, infiltrated and embedded
in Polybed 812 epoxy resin (Polysciences, Warrington, PA). One micron
sections were prepared to select representative areas by light microscopy
and 70 nm ultrathin sections were then cut with a diamond knife. Sections
weremounted on 200mesh copper grids and staining with 4% aqueous uranyl
acetate and Reynolds’ lead citrate. Sections were observedwith a LEO EM910
transmission electron microscope operating at 80 kV (LEO Electron Micros-
copy, Thornwood, NY) and photographed with a Gatan Orius SC1000 CCD
Digital Camera and Digital Micrograph 3.11.0 (Gatan, Pleasanton, CA).
Statistics
For all metabolic assays significant differences between experimental groups
were determined by two-tailed t test (p < 0.05). In experiments where more
than two groupswere compared such as themitotracker experiments, we per-
formed an ANOVA followed by a Tukey post hoc test to determine significant
differences. For gene expression, data were analyzed with R/limma (Smyth,
2004), and FDR and FDR-adjusted p values were calculated. For quantitative
mass spectrometry data, a Poisson regression analysis was performed to
determine significance of differentially expressed proteins between samples.
All data are expressed as mean ± SE.
ACCESSION NUMBERS
Microarray data have been deposited in the GEO database under accession
number GSE27590. Proteomics data have been deposited in the PRIDE data-
base under accession numbers 16851–16856.
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